An article published by Merlin researchers from UNIPD has recently been published in the “Leukemia” journal. The piece is entitled “Mouse mesenchymal stem cells inhibit high endothelial cell activation and lymphocyte homing to lymph nodes by releasing TIMP-1” (Author(s): Zanotti L, Angioni R, Calì B, Soldani C, Ploia C, Moalli F, Gargesha M, D’Amico G, Elliman S, Tedeschi G, Maffioli E, Negri A, Zacchigna S, Sarukhan A, Stein JV, Viola A) and appears in the May issue. The article deals with the impact of MSC on immunity and inflammation and identifies TIMP-1 as a novel biomarker for MSC-based therapy. You can access the article here.
- Joining up of EU's best expertise on this scale should benefit every year thousands of patients with diseases requi… t.co/8xQXuN63eo Time ago 2 Days via Hootsuite
- @wellcometrust asks a valid question here. What's your opinion? t.co/cjo5ZKZFbE Time ago 14 Days via Twitter Web Client
- This week @FP7Merlin researcher @DrDeeds3 of @Orbsen reports from #ISCTEU2018! t.co/W201EglEnK Time ago 14 Days via Twitter Web Client
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.